Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Infliximab, a monoclonal antibody targeting tumor necrosis factor alpha (TNF-alpha), has revolutionized the management of chronic inflammatory diseases such as rheumatoid arthritis (RA) and Crohn's disease (CD). This review explores the intricate mechanisms through which Infliximab exerts its therapeutic effects and its clinical applications in the... Read More»
: J Pulm Res Dis 2024
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals